| pyruvate |
drug |
4 |
2 |
|
| Qiagen |
drug |
10 |
2 |
|
| Qiagen DNeasy Blood and Tissue Kit |
drug |
3 |
1 |
DNeasy Blood & Tissue Kit |
| QIMR |
cohort |
9 |
5 |
Australia: QIMR, Australian (QIMR), QIMR cohort, QIMR cohorts, QIMR sample, Queensland Institute of Medical Research |
| qPCR |
drug |
5 |
3 |
quantitative PCR |
| quality of life |
phenotype |
9 |
5 |
QOL, QoL, quality of life measure |
| QuantiSNP |
drug |
2 |
2 |
|
| quantitative phenotypes |
phenotype |
6 |
3 |
|
| quantity of alcohol consumed |
phenotype |
8 |
3 |
alcohol consumption, patient’s report of quantity of drinking |
| Qubit |
drug |
4 |
— |
|
| RAC1 |
gene |
6 |
1 |
Rac GTPase, Rac1, Ras-related C3 botulinum toxin substrate 1 |
| race/ethnicity |
phenotype |
57 |
24 |
African American, African-American, Black, Caucasian, Ethnicity, European American, Hispanic, Minorities, Other, RACE.i, RACE·i, Race, Race variables, ethnic groups, ethnicity, non-Hispanic black, non-Hispanic white, other, other ethnicity, participant race, race, race/ethnicity, racial differences, racial group, racial groups, racial/ethnic groups, self-reported race/ethnicity, self‑reported race/ethnicity |
| racial groups |
cohort |
4 |
2 |
racial categories, racial groups, three racial groups |
| racism |
phenotype |
5 |
3 |
measures of racism |
| radial diffusivity |
phenotype |
4 |
2 |
λT |
| Raf1 |
gene |
5 |
3 |
Raf, Rafl kinase |
| Rap1gap |
gene |
2 |
2 |
|
| rapamycin |
drug |
4 |
2 |
Sirolimus, sirolimus |
| RARA |
gene |
5 |
5 |
RAR, RARα, retinoic acid receptor, retinoic acid receptor alpha |
| rare CNV |
variant |
5 |
5 |
CNV, Copy-number variation, copy number variation, rare CNVs, rare copy number variant, rare copy number variation |
